Latest Insider Transactions at Clene Inc. (CLNN)
This section provides a real-time view of insider transactions for Clene Inc. (CLNN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Clene Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Clene Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 21
2025
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,401
-0.48%
|
$17,005
$5.34 P/Share
|
|
Jun 04
2025
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
600
-0.08%
|
$2,400
$4.04 P/Share
|
|
Jun 02
2025
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
600
-0.08%
|
$2,400
$4.12 P/Share
|
|
May 30
2025
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
410
-0.06%
|
$820
$2.8 P/Share
|
|
May 29
2025
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
410
-0.06%
|
$820
$2.73 P/Share
|
|
May 28
2025
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
420
-0.06%
|
$840
$2.6 P/Share
|
|
May 27
2025
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
420
-0.06%
|
$840
$2.45 P/Share
|
|
Mar 19
2025
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,400
-0.2%
|
$5,600
$4.4 P/Share
|
|
Mar 18
2025
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,333
-0.19%
|
$5,332
$4.45 P/Share
|
|
Sep 30
2024
|
Alison Mosca Director |
BUY
Grant, award, or other acquisition
|
Indirect |
159,134
+33.14%
|
$636,536
$4.59 P/Share
|
|
Sep 30
2024
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
92,307
+17.2%
|
$369,228
$4.75 P/Share
|
|
Sep 30
2024
|
Robert Dee Etherington Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+19.94%
|
$40,000
$4.75 P/Share
|
|
Sep 30
2024
|
Mark Mortenson Chief Science Officer |
BUY
Open market or private purchase
|
Direct |
20,512
+41.47%
|
$82,048
$4.75 P/Share
|
|
Jul 29
2024
|
Robert Dee Etherington Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,320
+47.54%
|
$81,960
$3.0 P/Share
|
|
May 01
2024
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
13,000
-0.08%
|
$0
$0.4 P/Share
|
|
Apr 30
2024
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
13,000
-0.08%
|
$0
$0.42 P/Share
|
|
Apr 24
2024
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.07%
|
$0
$0.33 P/Share
|
|
Apr 09
2024
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
22,500
-0.05%
|
$0
$0.39 P/Share
|
|
Nov 10
2023
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
250,002
+3.43%
|
$0
$0.41 P/Share
|
|
Jun 26
2023
|
John Henry Stevens |
BUY
Open market or private purchase
|
Direct |
316,455
+28.34%
|
$0
$0.8 P/Share
|
|
Jun 26
2023
|
Robert Dee Etherington Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
25,000
+50.0%
|
$0
$0.81 P/Share
|
|
Jun 16
2023
|
Chidozie Ugwumba |
BUY
Open market or private purchase
|
Indirect |
7,500,000
+36.55%
|
$0
$0.8 P/Share
|
|
Jun 16
2023
|
Alison Mosca Director |
BUY
Open market or private purchase
|
Indirect |
2,394,375
+42.51%
|
$0
$0.8 P/Share
|
|
Jun 16
2023
|
Jonathon Gay Director |
BUY
Open market or private purchase
|
Indirect |
105,625
+50.0%
|
$0
$0.8 P/Share
|
|
Jun 16
2023
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
1,500,000
+18.09%
|
$0
$0.8 P/Share
|
|
Nov 14
2022
|
Reed N Wilcox Director |
BUY
Exercise of conversion of derivative security
|
Direct |
174,912
+23.32%
|
$0
$0.15 P/Share
|
|
Nov 02
2022
|
Jonathon Gay Director |
BUY
Open market or private purchase
|
Indirect |
990,099
+31.48%
|
$990,099
$1.01 P/Share
|
|
Nov 02
2022
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
2,871,287
+35.17%
|
$2,871,287
$1.01 P/Share
|
|
Nov 02
2022
|
John Henry Stevens |
BUY
Open market or private purchase
|
Direct |
148,515
+23.49%
|
$148,515
$1.01 P/Share
|
|
Nov 02
2022
|
Alison Mosca Director |
BUY
Open market or private purchase
|
Indirect |
792,079
+48.41%
|
$792,079
$1.01 P/Share
|
|
Nov 02
2022
|
Chidozie Ugwumba |
BUY
Open market or private purchase
|
Indirect |
990,099
+15.21%
|
$990,099
$1.01 P/Share
|
|
Aug 17
2022
|
John Henry Stevens |
BUY
Open market or private purchase
|
Direct |
47,662
+12.45%
|
$142,986
$3.85 P/Share
|
|
Jul 18
2022
|
Robert Dee Etherington Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,483
-29.33%
|
$93,932
$4.72 P/Share
|
|
Jun 17
2022
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
74,610
+2.99%
|
$149,220
$2.51 P/Share
|
|
Jun 16
2022
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
75,000
+3.1%
|
$150,000
$2.5 P/Share
|
|
Jun 16
2022
|
Mark Mortenson Chief Science Officer |
SELL
Open market or private sale
|
Direct |
20,247
-10.71%
|
$40,494
$2.47 P/Share
|
|
Jun 15
2022
|
Alison Mosca Director |
BUY
Open market or private purchase
|
Direct |
5,000
+11.24%
|
$10,000
$2.62 P/Share
|
|
Jun 15
2022
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
45,000
+1.94%
|
$90,000
$2.66 P/Share
|
|
Jun 14
2022
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
51,011
+2.24%
|
$102,022
$2.66 P/Share
|
|
Jun 13
2022
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
55,000
+2.46%
|
$165,000
$3.06 P/Share
|
|
Jun 06
2022
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
50,670
+2.33%
|
$101,340
$2.57 P/Share
|
|
Jun 03
2022
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
10,000
+0.48%
|
$20,000
$2.46 P/Share
|
|
May 27
2022
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
35,000
+1.67%
|
$70,000
$2.27 P/Share
|
|
May 16
2022
|
Robert Glanzman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,717
-30.87%
|
$9,434
$2.03 P/Share
|
|
May 16
2022
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
181,818
+8.23%
|
$363,636
$2.2 P/Share
|
|
May 16
2022
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
181,818
-1.16%
|
$363,636
$2.2 P/Share
|
|
May 16
2022
|
Jonathon Gay Director |
BUY
Open market or private purchase
|
Direct |
10,000
+12.7%
|
$20,000
$2.08 P/Share
|
|
May 02
2022
|
Reed N Wilcox Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+19.99%
|
$0
$0.15 P/Share
|
|
Apr 21
2022
|
General Resonance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
132,891
-0.84%
|
$398,673
$3.01 P/Share
|
|
Apr 20
2022
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
132,891
+6.72%
|
$398,673
$3.01 P/Share
|